Searchable abstracts of presentations at key conferences in endocrinology

ea0032p105 | Bone and Osteoporosis | ECE2013

Possible benefits of PTH 1–84 therapy in pregnancy and lactation osteoporosis (PLO)

Pastore Renato

Introduction: Pregnancy and lactation associated osteoporosis (PLO) is a rare condition in which women typically present with fractures, often vertebral, in the third trimester of pregnancy or in the early postpartum period. Bone loss of 3–10% at the spine and hip are seen over 3–6 months of lactation. Bone loss is related to duration of lactation and amenorrhea and is not prevented by calcium supplementation.Methods: We studied a woma...

ea0032p270 | Clinical case reports - Thyroid / Others | ECE2013

Low TSH plasma levels and high fracture risk in postmenopausal osteoporosis and osteopenia patients

Pastore Renato , Mentuccia Daniela

Introduction: Bone loss in thyroid dysfunction was first described by von Recklinghausen. Elevated bone turnover and decreased bone mass result when thyroid hormone levels are high and TSH levels suppressed. The changes in bone mass are impressive even in patients whit subclinical hypertiroidism, where thyroid hormones are within the normal range, but TSH is low or undetectable. Evidence show that endogenous and exogenous TSH suppression is associated with an increased fractur...

ea0037ep988 | Thyroid (non-cancer) | ECE2015

Levothyroxine therapy in comparison: fixed vs alternating dosage in subclinical hypothyroidism

Pastore Renato , Cannuccia Amalia , Simona Frontoni

Introduction: Oral levothyroxine (L-T4) is the standard treatment for hypothyroidism and serum TSH represents the best marker for assessing the proper L-T4 dose. The absorption and bioequivalence of different commercial L-T4 preparations might be variable. The aim of this study is to compare the efficacy of L-T4 using alternating doses vs fixed ones.Me...

ea0035p1019 | Thyroid (non-cancer) | ECE2014

Oral solution of levothyroxine vs tablets in subclinical hypothyroidism: evaluation of outcomes

Pastore Renato , Mentuccia Daniela , Ylli Dorina , Ilaria Giordani , Simona Frontoni

Introduction: Oral levothyroxine (LT4) is the standard treatment for hypothyroidism and serum TSH represents the best marker for assessing the proper LT4 dose. The absorption and bioequivalence of different commercial LT4 preparations might be variable. The aim of this study is to compare the efficacy of levothyroxine oral solution vs tablets.Methods: Fifty-eight patients (six males, 52 females; average age, 46.9±12....